CN Patent

CN119421883A — 用于治疗trpm3介导的病症的新型衍生物

Assigned to Baiaohaifen Therapeutics Co ltd · Expires 2025-02-11 · 1y expired

What this patent protects

本发明涉及可用于预防或治疗TRPM3介导的病症，更具体地选自疼痛、癫痫和炎性超敏反应的病症的化合物。本发明还涉及一种用于预防或治疗所述TRPM3介导的病症的方法。

USPTO Abstract

本发明涉及可用于预防或治疗TRPM3介导的病症，更具体地选自疼痛、癫痫和炎性超敏反应的病症的化合物。本发明还涉及一种用于预防或治疗所述TRPM3介导的病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN119421883A
Jurisdiction: CN
Classification: —
Expires: 2025-02-11
Drug substance claim: No
Drug product claim: No
Assignee: Baiaohaifen Therapeutics Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.